TY - JOUR T1 - Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study JF - The Journal of Rheumatology JO - J Rheumatol SP - 998 LP - 998 DO - 10.3899/jrheum.150613.C1 VL - 43 IS - 5 A2 - , Y1 - 2016/05/01 UR - http://www.jrheum.org/content/43/5/998.abstract N2 - Tanaka Y, Emoto K, Cai Z, Aoki T, Schlichting D, Rooney T, et al. Efficacy … ER -